RBC Capital Starts Forward Pharma (FWP) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
JMP Securities Starts Forward Pharma (FWP) at Market Outperform
November 10, 2014 8:06 AM ESTJMP Securities initiated coverage on Forward Pharma (NASDAQ: FWP) with a Market Outperform rating and a price target of $29.00.
For an analyst ratings summary and ratings history on Forward Pharma click here. For more ratings news on Forward Pharma click here.
Shares of Forward Pharma closed at $21.05 yesterday.
... More